Clinical trials
Recruiting Phase 2 Lymphoma, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Miltenyi Biomedicine GmbH | 2 |
| AstraZeneca | 1 |
| Beijing Tongren Hospital | 1 |
| Brown University | 1 |
| Chi Kong Li | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| City of Hope Medical Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| ImmunityBio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 23 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Burkitt Lymphoma | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Hodgkin Disease | 2 |
| Lymphoma | 2 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.